The U.S. Food and Drug Administration’s regulation of mobile health products is a definite gray area, and that was reflected during Wednesday night’s #mHealth tweet chat.
Most of the participants — who ranged from medical students to physicians to health IT professionals — agreed that some kind of approval process is needed in order to protect patients, but that the FDA doesn’t have the resources required to regulate all of them.
The challenge, then, comes in defining what should be reviewed and who should do the reviewing. One tweeter suggested that medical societies regulate their own specialty’s apps. Would that free the hands of the FDA any?
Below are some highlights from the chat.
Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.
By Deanna Pogorelc MedCity News
Deanna Pogorelc is a Cleveland-based reporter who writes obsessively about life science startups across the country, looking to technology transfer offices, startup incubators and investment funds to see what’s next in healthcare. She has a bachelor’s degree in journalism from Ball State University and previously covered business and education for a northeast Indiana newspaper.More posts by Author
- Get Livefyre
- FAQ
